CoreRx Announces Sitakant Chaudhury As Chief Financial Officer

CLEARWATER, Fl — CoreRx, Inc., an industry leading CDMO with formulation, development and GMP manufacturing sites in Clearwater, Florida and San Rafael, California, is pleased to announce the appointment of Sitakant (S.K.) Chaudhury as Chief Financial Officer and as a member of CoreRx’s Executive Leadership Team.

Mr. Chaudhury, a Global Finance Executive and Leader, brings to CoreRx over 25 years of experience building, scaling, transforming and leading world-class organizations. Most recently he worked as Chief Financial Officer of Tennessee-based Aphena Pharma Solutions. He has worked with and consulted for entrepreneurial start-ups and for large organizations, with noted achievements including 9 successful M&A transactions.

In his role as Chief Financial Officer, Sitakant will oversee CoreRx’s finance, accounting, controlling and IT functions and will also be responsible for leading the implementation of CoreRx’s ERP platform. Additionally, Sitakant will work closely with CoreRx’s Executive Leadership Team in planning, assessing, developing and executing against CoreRx’s strategic plan and growth initiatives, including all M&A, capacity expansion and technology acquisition activities.

“This is a very exciting time for CoreRx, with significant growth activities occurring across nearly every aspect of our business”, said Ajay Damani, CEO, “S.K. will make an important contribution in managing and accelerating our growth as we continue to expand capabilities, capacity and geography”.

ABOUT: CoreRx, Inc. is an industry leading Contract Development and Manufacturing Organization (CDMO), providing innovative drug formulation, development, GMP manufacturing and packaging solutions to global pharmaceutical and bio-pharmaceutical partners. From its state-of-the-art, multi-site campus in Clearwater, Florida and its early product development center in San Rafael, California, CoreRx delivers value-added solutions to its partners, from clinic to commercial scale and across a range of dosage forms.

For more information on CoreRx, please visit www.corerxpharma.com and follow CoreRx on LinkedIn www.linkedin.com/company/corerx-inc-

CONTACT:

William Sirico
William.Sirico@CoreRxPharma.com